Indication
Paralytic ileus prevention
Paralytic ileus prevention refers to clinical and pharmacological strategies designed to mitigate the temporary disruption or cessation of gastrointestinal motility in the absence of a mechanical obstruction. Read more about Paralytic ileus prevention
0 drugs 0 manufacturers
Drugs that treat it
Common Paralytic ileus prevention therapies.
No drugs are available
This indication does not currently contain public drugs.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonParalytic ileus prevention refers to clinical and pharmacological strategies designed to mitigate the temporary disruption or cessation of gastrointestinal motility in the absence of a mechanical obstruction.
This functional impairment predominantly affects surgical and hospitalized populations, arising most frequently following abdominal or pelvic operations, severe systemic illness, or opioid administration.
Pathophysiologically, it results from surgical manipulation, local neurogenic reflex hyperactivity, activation of local inflammatory cascades within the muscularis externa, and disruption of enteric neurotransmission.
Prophylaxis targets these mechanisms to prevent hallmark manifestations such as marked abdominal distension, nausea, vomiting, delayed passage of flatus or stool, and intolerance to enteral nutrition.
- nih.gov
Paralytic ileus prevention refers to clinical and pharmacological strategies designed to mitigate the temporary disruption or cessation of gastrointestinal motility in the absence of a mechanical obstruction
- nih.gov
Paralytic ileus prevention refers to clinical and pharmacological strategies designed to mitigate the temporary disruption or cessation of gastrointestinal motility in the absence of a mechanical obstruction This functional impairment predominantly affects surgical and hospitalized populations, arising most frequently following abdominal or pelvic operations, severe systemic illness, or opioid administration Pathophysiologically, it results from surgical manipulation, local neurogenic reflex hyp...
- nih.gov
This functional impairment predominantly affects surgical and hospitalized populations, arising most frequently following abdominal or pelvic operations, severe systemic illness, or opioid administration
- nih.gov
This functional impairment predominantly affects surgical and hospitalized populations, arising most frequently following abdominal or pelvic operations, severe systemic illness, or opioid administration Prophylaxis targets these mechanisms to prevent hallmark manifestations such as marked abdominal distension, nausea, vomiting, delayed passage of flatus or stool, and intolerance to enteral nutrition
- nih.gov
Pathophysiologically, it results from surgical manipulation, local neurogenic reflex hyperactivity, activation of local inflammatory cascades within the muscularis externa, and disruption of enteric neurotransmission
Personalize your experience
Follow Paralytic ileus prevention and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.